Polypeptides and methods for thymic vaccination
CA 2392387 A1 · Owner: Wang, Jia-Huai · Inventors: Wang, Jia-Huai; Sasada, Tetsuro; Reinherz, Ellis L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of thymic vaccination are described in which a polypeptide of , interest is administered and which allows positive or negative selection of a T cell receptor (TCR) specificity in the thymus to retain a desired , specificity (positive) or to eliminate an undesired specificity (negative) at the level of TCR repertoire development in order to generate TCRs which are , designed to recognize disease antigens or foreign antigens such as to treat , or prevent cancers, autoimmune diseases infections, or effects of biological , warfare agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 16, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.